MRTX - Mirati Therapeutics, Inc.
Close
58.7
-0.100 -0.170%
Share volume: 0
Last Updated: Mon 22 Jan 2024 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$58.80
-0.10
-0.17%
Summary score
21%
Profitability
18%
Dept financing
4%
Liquidity
75%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.36%
Return on assets
-13.61%
Return on sales
-13941.93%
Return on invested capital
-4263.63%
Total debt ratio
12.96%
Debt ratio change over timeo
-0.96%
Current Ratio
10.23%
Quick Ratio
10.21%
Cash Position Ratio
10.01%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.77%
Return on assets
-18.01%
Return on sales
-6947.46%
Return on invested capital
423.18%
Total debt ratio
17.56%
Debt ratio change over timeo
-0.96%
Current Ratio
6.97%
Quick Ratio
6.91%
Cash Position Ratio
6.68%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-17.11%
Return on assets
-15.23%
Return on sales
-1049.11%
Return on invested capital
370.06%
Total debt ratio
16.22%
Debt ratio change over time
-0.96%
Current Ratio
7.54%
Quick Ratio
7.4%
Cash Position Ratio
7.11%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.11%
Return on assets
-104.57%
Return on sales
-5525%
Return on invested capital
-629.92%
Total debt ratio
-95.53%
Debt ratio change over time
-0.96%
Current Ratio
3.01%
Quick Ratio
3.01%
Cash Position Ratio
2.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -15.36% | 0% | 0% | -117.6% |
| Return on assets | -13.61% | 0% | 0% | -11.99% |
| Return on sales | -13941.93% | 0% | 0% | -8680.79% |
| Return on invested capital | -4263.63% | 0% | 0% | -48.11% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 12.96% | 0% | 0% | 77.42% |
| Debt ratio change over time | -0.96% | 0% | 0% | -0.81% |
| Dept financing | 4% | 0% | 25% | 25% |
| Current Ratio | 6.97% | 0% | 0% | 5.35% |
| Quick Ratio | 6.91% | 0% | 0% | 5.34% |
| Cash Position Ratio | 6.68% | 0% | 0% | 5.03% |
| Liquididy | 75% | 0% | 0% | 58% |
| Short-term ratios | MRTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -20.77% | 0% | 0% | 146.7% |
| Return on assets | -18.01% | 0% | 0% | -18.66% |
| Return on sales | -6947.46% | 0% | 0% | -28500.29% |
| Return on invested capital | 423.18% | 0% | 0% | -371.75% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 17.56% | 0% | 0% | 108.07% |
| Debt ratio change over time | -0.96% | 0% | 0% | -1.53% |
| Dept financing | 4% | 0% | 25% | 25% |
| Current Ratio | 6.97% | 0% | 0% | 5.35% |
| Quick Ratio | 6.91% | 0% | 0% | 5.34% |
| Cash Position Ratio | 6.68% | 0% | 0% | 5.03% |
| Liquididy | 75% | 0% | 0% | 57% |